CCND1 and melanoma: It has been found that the administration of lupeol has produced a dose-dependent reduction in the levels of β-catenin and WNT target genes, namely coding the region determinant-binding protein (CRD-BP), MITF and CCND1, which was in contradiction to Mel 1011 melanoma cells.